May 5, 2020
Pathway Rx Advances Research that Shows Potential for Medical Cannabis to Treat COVID-19
Data collected from previous studies conducted in collaboration with Swysh and commercial partner Sundial Growers reveals that some medical cannabis cultivars can help reduce the severity and complications of COVID-19 disease
LETHBRIDGE, May 5, 2020 /CNW/ -- Pathway RX Inc. (“Pathway Rx”), a research company dedicated to developing custom cannabis therapies to treat specific diseases and Swysh Inc. (“Swysh”), a cannabinoid oral health product developer, today announced that they intend to further advance their research to evaluate the potential for medical cannabis to treat COVID-19 and its possible complications. These efforts will include the publication of more research papers and the initiation of clinical trials to validate the safety and efficacy of medical cannabis to treat COVID-19.